Literature DB >> 18951466

Laboratory testing for fibrinogen abnormalities.

Madeleine Verhovsek1, Karen A Moffat, Catherine P M Hayward.   

Abstract

Fibrinogen is essential for the formation of a fibrin clot. Acquired and congenital disorders of fibrinogen may result in decreased concentration or altered function of fibrinogen, often leading to an increased risk of bleeding. Routine coagulation testing and specialized laboratory investigations can guide diagnosis in patients suspected of having a fibrinogen abnormality. This article summarizes the types of laboratory assays that are used to assess fibrinogen disorders, and key abnormalities found in different types of fibrinogen disorders. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18951466     DOI: 10.1002/ajh.21293

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

1.  Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease.

Authors:  Rehana S Lovely; Steven C Kazmierczak; Joseph M Massaro; Ralph B D'Agostino; Christopher J O'Donnell; David H Farrell
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

2.  Determination of plasma fibrinogen concentrations in beagle dogs, cynomolgus monkeys, New Zealand white rabbits, and Sprague-Dawley rats by using Clauss and prothrombin-time-derived assays.

Authors:  Mehrdad Ameri; Henry A Schnaars; John R Sibley; David J Honor
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-11       Impact factor: 1.232

3.  Ovariectomy differential influence on some hemostatic markers of mice and rats.

Authors:  Cristina Lemini; Ruth Jaimez; Alejandra Figueroa; Lucía Martinez-Mota; María Estela Avila; Martha Medina
Journal:  Exp Anim       Date:  2014-10-14

Review 4.  Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.

Authors:  Megan O Nakashima; Heesun J Rogers
Journal:  Blood Res       Date:  2014-06-25

Review 5.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

Review 6.  Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders.

Authors:  Giovanni Luca Tiscia; Maurizio Margaglione
Journal:  Int J Mol Sci       Date:  2018-05-29       Impact factor: 5.923

7.  Correlation of plasma coagulation tests and fibrinogenClauss with rotational thromboelastometry parameters and prediction of bleeding in dogs.

Authors:  Nathalie M Enk; Annette P N Kutter; Claudia Kuemmerle-Fraune; Nadja E Sigrist
Journal:  J Vet Intern Med       Date:  2018-12-11       Impact factor: 3.333

Review 8.  Hereditary Thrombophilia in the Era of COVID-19.

Authors:  Oana Viola Badulescu; Paul Dan Sirbu; Nina Filip; Gabriela Bordeianu; Elena Cojocaru; Cristian Constantin Budacu; Minerva Codruta Badescu; Iris Bararu-Bojan; Bogdan Veliceasa; Manuela Ciocoiu
Journal:  Healthcare (Basel)       Date:  2022-05-27

9.  Identification and characterization of novel mutations implicated in congenital fibrinogen disorders.

Authors:  Natalie Smith; Larissa Bornikova; Leila Noetzli; Hugo Guglielmone; Salvador Minoldo; Donald S Backos; Linda Jacobson; Courtney D Thornburg; Miguel Escobar; Tara C White-Adams; Alisa S Wolberg; Marilyn Manco-Johnson; Jorge Di Paola
Journal:  Res Pract Thromb Haemost       Date:  2018-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.